← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cel-Sci Corporation
Vienna, VA
$2,887,781
Total funding
6
Grants
Funding over time
peak $806.5K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,887,781 · 6
By mechanism
R44$2,262,090 · 2
R43$625,691 · 4
Investigators at Cel-Sci Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis$806,505
R44 · FY2017 · AR
Preclinical studies of PG70 LEAPS peptide vaccines for rheumatoid arthritis$691,469
R44 · FY2018 · AR
HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS$385,063
R44 · FY2001 · AI
HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS$379,053
R44 · FY2000 · AI
Preclinical Studies of PG70 LEAPS Peptide Vaccines for Rheumatoid Arthritis$224,999
R43 · FY2014 · AR
derG Immunostimulant Prevention/Treatment of HSV Disease$162,132
R43 · FY2003 · AI
Peptide Vaccine for Experimental Autoimmune Myocarditis$134,469
R43 · FY2003 · HL
Augmenting innate and vaccine immune response with der-G$104,091
R43 · FY2003 · AI